{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:09:49Z","timestamp":1789524589051,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Research Council of Thailand (NRCT) fiscal year 2023"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10067-026-07967-6","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:04:49Z","timestamp":1770278689000},"page":"2305-2317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a non-genetic risk prediction model for allopurinol-induced severe cutaneous adverse drug reactions: a multicenter retrospective observational study"],"prefix":"10.1007","volume":"45","author":[{"given":"Suppachai","family":"Lawanaskol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichittra","family":"Tassaneeyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlaphat","family":"Sukasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niwat","family":"Saksit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinya","family":"Konyoung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nontaya","family":"Nakkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warayuwadee","family":"Amornpinyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ticha","family":"Rerkpattanapipat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jettanong","family":"Klaewsongkram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawinee","family":"Rerknimitr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thawinee","family":"Jantararoungtong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangkamon","family":"Poolpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittiphan","family":"Chalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichat","family":"Tantraworasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanton","family":"Patumanond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worawit","family":"Louthrenoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-7651","authenticated-orcid":false,"given":"Patapong","family":"Towiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"6","key":"7967_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/art.41247","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D, King C, Levy G, Libbey C, Mount D, Pillinger MH, Rosenthal A, Singh JA, Sims JE, Smith BJ, Wenger NS, Bae SS, Danve A, Khanna PP, Kim SC, Lenert A, Poon S, Qasim A, Sehra ST, Sharma TSK, Toprover M, Turgunbaev M, Zeng L, Zhang MA, Turner AS, Neogi T (2020) 2020 American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol 72(6):879\u2013895. https:\/\/doi.org\/10.1002\/art.41247","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"7967_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrrheum.2015.132","volume":"12","author":"LK Stamp","year":"2016","unstructured":"Stamp LK, Day RO, Yun J (2016) Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol 12(4):235\u2013242. https:\/\/doi.org\/10.1038\/nrrheum.2015.132","journal-title":"Nat Rev Rheumatol"},{"key":"7967_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00186","volume":"7","author":"C Sukasem","year":"2016","unstructured":"Sukasem C, Jantararoungtong T, Kuntawong P, Puangpetch A, Koomdee N, Satapornpong P, Supapsophon P, Klaewsongkram J, Rerkpattanapipat T (2016) HLA-B (*) 58:01 for allopurinol-induced cutaneous adverse drug reactions: implication for clinical interpretation in Thailand. Front Pharmacol 7:186. https:\/\/doi.org\/10.3389\/fphar.2016.00186","journal-title":"Front Pharmacol"},{"issue":"9","key":"7967_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","volume":"19","author":"W Tassaneeyakul","year":"2009","unstructured":"Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W (2009) Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 19(9):704\u2013709. https:\/\/doi.org\/10.1097\/FPC.0b013e328330a3b8","journal-title":"Pharmacogenet Genomics"},{"issue":"11","key":"7967_CR5","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 102(11):4134\u20134139. https:\/\/doi.org\/10.1073\/pnas.0409500102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"7967_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/1756-185x.13143","volume":"20","author":"KH Yu","year":"2017","unstructured":"Yu KH, Yu CY, Fang YF (2017) Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis. Int J Rheum Dis 20(9):1057\u20131071. https:\/\/doi.org\/10.1111\/1756-185x.13143","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"7967_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/fpc.0000000000000285","volume":"27","author":"N Saksit","year":"2017","unstructured":"Saksit N, Tassaneeyakul W, Nakkam N, Konyoung P, Khunarkornsiri U, Chumworathayi P, Sukasem C, Suttisai S, Piriyachananusorn N, Tiwong P, Chaiyakunapruk N, Sawanyawisuth K, Rerkpattanapipat T, Tassaneeyakul W (2017) Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. Pharmacogenet Genomics 27(7):255\u2013263. https:\/\/doi.org\/10.1097\/fpc.0000000000000285","journal-title":"Pharmacogenet Genomics"},{"issue":"Database issue","key":"7967_CR8","doi-asserted-by":"publisher","first-page":"D784","DOI":"10.1093\/nar\/gku1166","volume":"43","author":"FF Gonz\u00e1lez-Galarza","year":"2015","unstructured":"Gonz\u00e1lez-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, da Silva AL, Teles e Silva AL, Ghattaoraya GS, Alfirevic A, Jones AR, Middleton D (2015) Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res 43(Database issue):D784-788. https:\/\/doi.org\/10.1093\/nar\/gku1166","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"7967_CR9","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/art.34488","volume":"64","author":"LK Stamp","year":"2012","unstructured":"Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, Dalbeth N (2012) Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum 64(8):2529\u20132536. https:\/\/doi.org\/10.1002\/art.34488","journal-title":"Arthritis Rheum"},{"issue":"8","key":"7967_CR10","doi-asserted-by":"publisher","first-page":"e70093","DOI":"10.1002\/acr2.70093","volume":"7","author":"P Dilokthornsakul","year":"2025","unstructured":"Dilokthornsakul P, Louthrenoo W, Yadee J, Siripaitoon B, Jatuworapruk K, Vannaprasaht S, Rerkpattanapipat T, Chungcharoenpanich A, Iamsumang W, Upakdee N, Dechanont S, Lawanaskol S, Butthum B, Chevaisrakul P, Towiwat P (2025) An updated economic evaluation of HLA-B*58:01 genotype testing in gouty patients for preventing severe allopurinol hypersensitivity in Thailand. ACR Open Rheumatol 7(8):e70093. https:\/\/doi.org\/10.1002\/acr2.70093","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"7967_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/fpc.0000000000000319","volume":"28","author":"HY Chong","year":"2018","unstructured":"Chong HY, Lim YH, Prawjaeng J, Tassaneeyakul W, Mohamed Z, Chaiyakunapruk N (2018) Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Malaysian population. Pharmacogenet Genomics 28(2):56\u201367. https:\/\/doi.org\/10.1097\/fpc.0000000000000319","journal-title":"Pharmacogenet Genomics"},{"issue":"13","key":"7967_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2217\/pgs-2023-0095","volume":"24","author":"KN Duong","year":"2023","unstructured":"Duong KN, Nguyen DV, Chaiyakunapruk N, Nelson RE, Malone DC (2023) Cost-effectiveness of HLA-B*58:01 testing to prevent Stevens-Johnson syndrome\/toxic epidermal necrolysis in Vietnam. Pharmacogenomics 24(13):713\u2013724. https:\/\/doi.org\/10.2217\/pgs-2023-0095","journal-title":"Pharmacogenomics"},{"issue":"16","key":"7967_CR13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.2217\/pgs.15.125","volume":"16","author":"D Dong","year":"2015","unstructured":"Dong D, Tan-Koi WC, Teng GG, Finkelstein E, Sung C (2015) Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore. Pharmacogenomics 16(16):1781\u20131793. https:\/\/doi.org\/10.2217\/pgs.15.125","journal-title":"Pharmacogenomics"},{"issue":"1","key":"7967_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13075-020-02273-1","volume":"22","author":"MD Do","year":"2020","unstructured":"Do MD, Mai TP, Do AD, Nguyen QD, Le NH, Le LGH, Hoang VA, Le AN, Le HQ, Richette P, Resche-Rigon M, Bardin T (2020) Risk factors for cutaneous reactions to allopurinol in Kinh Vietnamese: results from a case-control study. Arthritis Res Ther 22(1):182. https:\/\/doi.org\/10.1186\/s13075-020-02273-1","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"7967_CR15","first-page":"656","volume":"7","author":"A Markel","year":"2005","unstructured":"Markel A (2005) Allopurinol-induced DRESS syndrome. Isr Med Assoc J 7(10):656\u2013660","journal-title":"Isr Med Assoc J"},{"issue":"9","key":"7967_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/rheumatology\/kes091","volume":"51","author":"LK Stamp","year":"2012","unstructured":"Stamp LK, Barclay ML, O\u2019Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT (2012) Furosemide increases plasma oxypurinol without lowering serum urate\u2013a complex drug interaction: implications for clinical practice. Rheumatology (Oxford) 51(9):1670\u20131676. https:\/\/doi.org\/10.1093\/rheumatology\/kes091","journal-title":"Rheumatology (Oxford)"},{"key":"7967_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(25)00165-1","author":"E Cipolletta","year":"2025","unstructured":"Cipolletta E, Nakafero G, Rozza D, Mahil SK, Smith CH, Riley RD, Abhishek A (2025) Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/s2665-9913(25)00165-1","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"7967_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129(1):92\u201396","journal-title":"Arch Dermatol"},{"issue":"3","key":"7967_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC (2007) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156(3):609\u2013611. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07704.x","journal-title":"Br J Dermatol"},{"issue":"6","key":"7967_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461\u2013470. https:\/\/doi.org\/10.7326\/0003-4819-130-6-199903160-00002","journal-title":"Ann Intern Med"},{"issue":"3","key":"7967_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","volume":"100","author":"NH Lameire","year":"2021","unstructured":"Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC, Stevens PE (2021) Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 100(3):516\u2013526. https:\/\/doi.org\/10.1016\/j.kint.2021.06.028","journal-title":"Kidney Int"},{"issue":"3","key":"7967_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1536867X0400400301","volume":"4","author":"P Royston","year":"2004","unstructured":"Royston P (2004) Multiple imputation of missing values. Stata J 4(3):227\u2013241","journal-title":"Stata J"},{"issue":"6","key":"7967_CR23","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3899\/jrheum.080938","volume":"36","author":"N Schlesinger","year":"2009","unstructured":"Schlesinger N, Norquist JM, Watson DJ (2009) Serum urate during acute gout. J Rheumatol 36(6):1287\u20131289. https:\/\/doi.org\/10.3899\/jrheum.080938","journal-title":"J Rheumatol"},{"issue":"3","key":"7967_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/rhu.0000000000000235","volume":"21","author":"EM Hill","year":"2015","unstructured":"Hill EM, Sky K, Sit M, Collamer A, Higgs J (2015) Does starting allopurinol prolong acute treated gout? A randomized clinical trial. J Clin Rheumatol 21(3):120\u2013125. https:\/\/doi.org\/10.1097\/rhu.0000000000000235","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"7967_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","volume":"125","author":"TH Taylor","year":"2012","unstructured":"Taylor TH, Mecchella JN, Larson RJ, Kerin KD, Mackenzie TA (2012) Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 125(11):1126-1134.e1127. https:\/\/doi.org\/10.1016\/j.amjmed.2012.05.025","journal-title":"Am J Med"},{"issue":"2","key":"7967_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10067-020-05215-z","volume":"40","author":"X Zhang","year":"2021","unstructured":"Zhang X, Tang Y, Wang M, Wang D, Li Q (2021) The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials. Clin Rheumatol 40(2):701\u2013710. https:\/\/doi.org\/10.1007\/s10067-020-05215-z","journal-title":"Clin Rheumatol"},{"issue":"9","key":"7967_CR27","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","volume":"175","author":"CY Yang","year":"2015","unstructured":"Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, Wu CY, Hung SI, Chung WH (2015) Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med 175(9):1550\u20131557. https:\/\/doi.org\/10.1001\/jamainternmed.2015.3536","journal-title":"JAMA Intern Med"},{"key":"7967_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","volume":"368","author":"RD Riley","year":"2020","unstructured":"Riley RD, Ensor J, Snell KIE, Harrell FE Jr., Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M (2020) Calculating the sample size required for developing a clinical prediction model. BMJ 368:m441. https:\/\/doi.org\/10.1136\/bmj.m441","journal-title":"BMJ"},{"key":"7967_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2738784","volume":"2017","author":"N Saksit","year":"2017","unstructured":"Saksit N, Nakkam N, Konyoung P, Khunarkornsiri U, Tassaneeyakul W, Chumworathayi P, Kanjanawart S, Sukasem C, Sangviroon A, Pattanacheewapull O, Tassaneeyakul W (2017) Comparison between the HLA-B(\u2217)58\u2009:\u200901 allele and single-nucleotide polymorphisms in chromosome 6 for prediction of allopurinol-induced severe cutaneous adverse reactions. J Immunol Res 2017:2738784. https:\/\/doi.org\/10.1155\/2017\/2738784","journal-title":"J Immunol Res"},{"issue":"7","key":"7967_CR30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","volume":"136","author":"CY Ng","year":"2016","unstructured":"Ng CY, Yeh YT, Wang CW, Hung SI, Yang CH, Chang YC, Chang WC, Lin YJ, Chang CJ, Su SC, Fan WL, Chen DY, Wu YJ, Tian YC, Hui RC, Chung WH (2016) Impact of the HLA-B(*)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions. J Invest Dermatol 136(7):1373\u20131381. https:\/\/doi.org\/10.1016\/j.jid.2016.02.808","journal-title":"J Invest Dermatol"},{"key":"7967_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jclinepi.2021.08.028","volume":"144","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n MA (2022) Causal analyses of existing databases: no power calculations required. J Clin Epidemiol 144:203\u2013205. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.08.028","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"7967_CR32","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Liot\u00e9 F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ (2015) 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74(10):1789\u20131798. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237","journal-title":"Ann Rheum Dis"},{"key":"7967_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-118","volume":"12","author":"R Somkrua","year":"2011","unstructured":"Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N (2011) Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Med Genet 12:118. https:\/\/doi.org\/10.1186\/1471-2350-12-118","journal-title":"BMC Med Genet"},{"issue":"10","key":"7967_CR34","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","volume":"36","author":"SN Ramasamy","year":"2013","unstructured":"Ramasamy SN, Korb-Wells CS, Kannangara DR, Smith MW, Wang N, Roberts DM, Graham GG, Williams KM, Day RO (2013) Allopurinol hypersensitivity: a systematic review of all published cases, 1950\u20132012. Drug Saf 36(10):953\u2013980. https:\/\/doi.org\/10.1007\/s40264-013-0084-0","journal-title":"Drug Saf"},{"issue":"4","key":"7967_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3904\/kjim.2015.30.4.521","volume":"30","author":"HK Min","year":"2015","unstructured":"Min HK, Lee B, Kwok SK, Ju JH, Kim WU, Park YM, Park SH (2015) Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes. Korean J Intern Med 30(4):521\u2013530. https:\/\/doi.org\/10.3904\/kjim.2015.30.4.521","journal-title":"Korean J Intern Med"},{"issue":"1","key":"7967_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-01874-y","volume":"17","author":"G Sornsamdang","year":"2024","unstructured":"Sornsamdang G, Satapornpong P, Jinda P, Jantararoungtong T, Koomdee N, Tempark T, Klaewsongkram J, Rerkpattanapipat T, Rerknimitr P, Tuchinda P, Chularojanamontri L, Tovanabutra N, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Srisuttiyakorn C, Srinoulprasert Y, John S, Biswas M, Sukasem C (2024) Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients. BMC Med Genomics 17(1):101. https:\/\/doi.org\/10.1186\/s12920-024-01874-y","journal-title":"BMC Med Genomics"},{"issue":"10","key":"7967_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/gim.2014.195","volume":"17","author":"JW Jung","year":"2015","unstructured":"Jung JW, Kim DK, Park HW, Oh KH, Joo KW, Kim YS, Ahn C, Lee KW, Cho SH, Min KU, Kang HR (2015) An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing. Genet Med 17(10):807\u2013814. https:\/\/doi.org\/10.1038\/gim.2014.195","journal-title":"Genet Med"},{"issue":"2","key":"7967_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18(2):99\u2013107. https:\/\/doi.org\/10.1097\/FPC.0b013e3282f3ef9c","journal-title":"Pharmacogenet Genomics"},{"issue":"7","key":"7967_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218226","volume":"81","author":"N Quilis","year":"2022","unstructured":"Quilis N, Vela P, Blanco C\u00e1ceres BA, Diaz-Torne C, Calvo-Aranda E, Sivera F, Prada-Ojeda A, P\u00e9rez Ruiz F, Pascual E, Andr\u00e9s M (2022) Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland. Ann Rheum Dis 81(7):e124. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218226","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7967_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jbspin.2015.07.011","volume":"83","author":"T Bardin","year":"2016","unstructured":"Bardin T, Chal\u00e8s G, Pascart T, Flipo RM, Korng Ea H, Roujeau JC, Delayen A, Clerson P (2016) Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment. Joint Bone Spine 83(3):314\u2013317. https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.011","journal-title":"Joint Bone Spine"},{"key":"7967_CR41","doi-asserted-by":"publisher","unstructured":"Hosmer DW Jr, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley series in probability and statistics. John Wiley & Sons, Inc. https:\/\/doi.org\/10.1002\/9781118548387","DOI":"10.1002\/9781118548387"},{"key":"7967_CR42","volume-title":"Clinical epidemiology: principles, methods, and applications for clinical research","author":"DE Grobbee","year":"2014","unstructured":"Grobbee DE, Hoes AW (2014) Clinical epidemiology: principles, methods, and applications for clinical research, 2nd edn. Jones and Bartlett Publishers, Sudbury","edition":"2"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07967-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07967-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07967-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:21:23Z","timestamp":1773217283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07967-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7967"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07967-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study protocol was approved by Central Research Ethics Committee (COA-CREC027\/2023) including all primary care hospitals of Chiang Mai, Uthai Thani, Phitsanulok, Kamphaeng Phet, and Mukdahan; Faculty of Medicine, including Chulalongkorn University, Khon Kaen University, Chiang Mai University Hospital of Chiang Mai University, and Ramathibodi Hospital of Mahidol University; the Institute Review Board and Ethics Committee of the Naresuan University Hospital (IRB No. P3-0087\/2565) and Buddhachinaraj Hospital (HREC No. 033\/2566). All of their Ethics Committees were in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study did not involve consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"NoG-ASCAR Score\n                      web application can be accessed freely at\n                      \n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Addendum"}}]}}